Similar articles

• Role of the clinical biochemistry laboratory in the assessment of dyslipoproteinaemias.

  Ballantyne FC. Ballantyne FC. Ann Clin Biochem. 1984 May;21 ( Pt 3):166-75. doi: 10.1177/000456328402100302. Ann Clin Biochem. 1984. PMID: 6383181 Review. No abstract available.
• [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].

  Romics L, Karádi I, Simonyi E. Romics L, et al. Orv Hetil. 1980 Oct 26;121(43):2629-31. Orv Hetil. 1980. PMID: 7208011 Hungarian. No abstract available.
• Accuracy and reproducibility of a quantitative electrophoresis of plasma lipoproteins: interlaboratory comparison and verification by ultracentrifugation.

  Bojanovski D, Wippermann B, Molinari E, Schuster J, Canzler H. Bojanovski D, et al. Clin Chim Acta. 1981 Nov 11;116(3):381-7. doi: 10.1016/0009-8981(81)90057-7. Clin Chim Acta. 1981. PMID: 6945924
• Plasma lipoprotein metabolism in relation to ischaemic heart disease.

  Rogers MP. Rogers MP. Biochem Soc Trans. 1982 Jun;10(3):159-61. doi: 10.1042/bst0100159. Biochem Soc Trans. 1982. PMID: 7106365 No abstract available.
• Dietary and drug treatment of primary hyperlipoproteinemia.

  [No authors listed] [No authors listed] Ann Intern Med. 1972 Aug;77(2):267-94. doi: 10.7326/0003-4819-77-2-267. Ann Intern Med. 1972. PMID: 4345081 Review. No abstract available.